$0.000300
0.1755966.67%
At close: Dec 16, 4:00 PM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Scopus BioPharma in recent months.
Browse guidance and forecast on all stocks.